Back to Market Feed

AFINITOR 10 MG TABLET

everolimus
$462.0390per EA
High Outlier

Strength

10 mg/1

NDC

00078056751

Classification

Brand

Dosage Form

TABLET

Route

ORAL

Last Updated

1/4/2017

Active Ingredients

EVEROLIMUS

Approval Type

New Drug (NDA)

FDA Application

NDA022334

On Market Since

3/31/2009

Pharmacological Classes

Cytochrome P450 2D6 Inhibitors
Cytochrome P450 3A4 Inhibitors
Decreased Immunologic Activity
Kinase Inhibitor
Protein Kinase Inhibitors
mTOR Inhibitor Immunosuppressant
mTOR Inhibitors

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

0.0%

3Y

0.0%

5Y

0.0%

All

+54.8%

Generic Alternatives

Save up to 94%

2 alternatives • Same active ingredient

EVEROLIMUS 10 MG TABLET
Generic
70377001322•Biocon Pharma Inc.
$26.3242
Save 94%
EVEROLIMUS 10 MG TABLET
Generic
72603025701•NorthStar Rx LLC
$26.3242
Save 94%

Related Drugs

Same classification

TIAZAC ER 180 MG CAPSULE
Brand
00187261330•Bausch Health US LLC
$1.5060
per EA
TIAZAC ER 180 MG CAPSULE
Brand
00187261390•Bausch Health US LLC
$1.5060
per EA
MYRBETRIQ ER 8 MG/ML SUSP
Brand
00469502099•Astellas Pharma US, Inc.
$2.2097
per ML
TIAZAC ER 360 MG CAPSULE
Brand
00187261630•Bausch Health US LLC
$2.7628
per EA
TIAZAC ER 360 MG CAPSULE
Brand
00187261690•Bausch Health US LLC
$2.7628
per EA
NEORAL 25 MG GELATIN CAPSULE
Brand
00078024615•Novartis Pharmaceuticals Corporation
$2.8879
per EA
KALETRA 80 MG-20 MG/ML SOLN
Brand
00074395646•AbbVie Inc.
$3.1186
per ML
CARDIZEM LA 120 MG TABLET
Brand
00187204530•Bausch Health US LLC
$3.6467
per EA
CARDIZEM LA 120 MG TABLET
Brand
00187204590•Bausch Health US LLC
$3.6467
per EA
CARDIZEM LA 180 MG TABLET
Brand
00187204630•Bausch Health US LLC
$3.8314
per EA